Douglas Jermasek - Net Worth and Insider Trading

Douglas Jermasek Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Douglas Jermasek owns 1 companies in total, including Unicycive Therapeutics Inc (UNCY) .

Click here to see the complete history of Douglas Jermasek’s form 4 insider trades.

Insider Ownership Summary of Douglas Jermasek

Ticker Comapny Transaction Date Type of Owner
UNCY Unicycive Therapeutics Inc 2022-11-18 other: EVP of Corporate Strategy

Douglas Jermasek Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Douglas Jermasek Ownership Network

Ownership Network List of Douglas Jermasek

No Data

Ownership Network Relation of Douglas Jermasek

Insider Network Chart

Douglas Jermasek Owned Company Details

What does Unicycive Therapeutics Inc do?

Who are the key executives at Unicycive Therapeutics Inc?

Douglas Jermasek is the other: EVP of Corporate Strategy of Unicycive Therapeutics Inc. Other key executives at Unicycive Therapeutics Inc include Chief Financial Officer John Townsend , EVP & Pharmaceuticals and BD Pramod Gupta , and director & CEO Shalabh K. Gupta .

Unicycive Therapeutics Inc (UNCY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Unicycive Therapeutics Inc (UNCY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Unicycive Therapeutics Inc (UNCY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Unicycive Therapeutics Inc (UNCY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Unicycive Therapeutics Inc Insider Transactions

No Available Data

Douglas Jermasek Mailing Address

Above is the net worth, insider trading, and ownership report for Douglas Jermasek. You might contact Douglas Jermasek via mailing address: 4300 El Camino Real, Suite 210, Los Altos Ca 94022.

Discussions on Douglas Jermasek

No discussions yet.